OpenAI’s Sam Altman invested in bioscience aging startup

OpenAI’s Sam Altman rose to prominence after releasing ChatGPT late last year, but a different area of technology also piqued his interest. The tech entrepreneur has invested $180 million in a company that aims to reverse aging and extend human…








